National Pensions Awareness Week 2024
GP pension campaign in England At the end of July, the BMA’s pensions committee launched a campaign to assist GPs…
From 23 June, some people living with obesity may be eligible to access tirzepatide (Mounjaro®) for weight loss purposes in community settings as outlined in NICE guidelines. Access is prioritised for those with the greatest clinical need (see page 7 of the interim commissioning guidance for eligibility criteria).
Initially, only a small number of people are eligible, including those people living with obesity, in poor health with multiple obesity related conditions, as they are likely to benefit most from the treatment.
Access routes and services will differ across each ICB. Clinicians will need to await details from their ICB on the weight management pathway in the community. This will include pathways for prescribing as well as referring into a ‘wraparound’ offer.
A communications toolkit is available to support with communicating about how tirzepatide will be implemented locally.
GP pension campaign in England At the end of July, the BMA’s pensions committee launched a campaign to assist GPs…
The main medical charities have got together to produce a new website portal that will help doctors in difficulties to…
A new statutory medical examiner system is being rolled out across England and Wales to provide independent scrutiny of deaths, and to…
This two-minute video shows GPC England colleagues’ views on this specific collective action. We are asking you to consider extending…